Skip to main content
Mabion S.A. logo

Mabion S.A. — Investor Relations & Filings

Ticker · MAB ISIN · PLMBION00016 LEI · 259400KG5JVQPPZL6X53 WAR Manufacturing
Open in API
Filings indexed 1,002 across all filing types
Latest filing 2025-10-24 Capital/Financing Update
Country PL Poland
Listing WAR MAB

About Mabion S.A.

https://www.mabion.eu/en/

Mabion S.A. is an integrated Contract Development and Manufacturing Organization (CDMO) that provides end-to-end services for the development and manufacturing of protein-based biotherapeutics. The company specializes in monoclonal antibodies and biosimilars, offering a complete workflow from cell line development and banking to process optimization and large-scale GMP manufacturing. Core competencies include upstream processing using mammalian cell cultures, downstream purification involving chromatography and viral clearance, and technology transfer for scale-up. Mabion partners with pharmaceutical and biotechnology companies to support both clinical and commercial supply, streamlining the path from gene to final drug product.

Recent filings

Filing Released Lang Actions
Zawarcie z Twiti Investments Ltd. umowy pożyczki - Content (EN)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the conclusion of a loan agreement between Mabion S.A. and Twiti Investments Ltd. It details the terms of the financing, including the loan amount, interest rate, collateral, and conversion options. This falls under the category of company financing and capital structure updates.
2025-10-24 English
Zawarcie z Twiti Investments Ltd. umowy pożyczki - Content (PL)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement by Mabion S.A. regarding the signing of a loan agreement with a major shareholder (Twiti Investments Ltd.). It details the loan amount, interest rate, purpose, and security measures (mortgages, pledges). This falls under the category of company financing and capital structure updates, which is explicitly defined as 'Capital/Financing Update' (CAP).
2025-10-24 Polish
Informacja dotycząca stanowiska Zarządu i opinii Rady Nadzorczej Mabion S.A. odnoszących się do odmowy wydania wniosku wyrażonej przez firmę audytorską w raporcie z przeglądu półrocznego skróconego...
Audit Report / Information Classification · 100% confidence The document is an official announcement from Mabion S.A. regarding a refusal by their audit firm to issue a conclusion on the company's semi-annual financial statements. It describes a significant regulatory event (audit disclaimer) and explicitly states that the company will publish further information at a later date. This fits the definition of a regulatory announcement regarding a specific corporate event that does not constitute the financial report itself, but rather a disclosure of a material development. H1 2025
2025-10-08 Polish
Raport Biegłego Rewidenta
Audit Report / Information Classification · 100% confidence The document is a 'Report on the review of the condensed interim financial statements' (Raport z przeglądu skróconego śródrocznego sprawozdania finansowego) issued by an independent auditor (Grant Thornton Polska) for Mabion S.A. It explicitly states that the auditor is unable to express a conclusion due to significant uncertainties regarding the company's going concern status. This is a standalone audit review report concerning interim financial statements, which falls under the 'Audit Report / Information' category. H1 2025
2025-10-08 Polish
Oświadczenie Zarządu w sprawie rzetelności sporządzenia sprawozdania finansowego
Regulatory Filings Classification · 95% confidence The document is a formal 'Statement of the Management Board' (Oświadczenie Zarządu) certifying the reliability of financial statements for the 6-month period ending June 30, 2025. It does not contain the actual financial statements or substantive financial data, but rather serves as an officer certification/attestation. According to the 'Certification Rule', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS) rather than the report they reference. H1 2025
2025-10-08 Polish
Mabion_Sprawozdanie Zarządu_1H2025
Interim / Quarterly Report Classification · 100% confidence The document is a 'Sprawozdanie Zarządu z działalności Mabion S.A. w I półroczu 2025 roku' (Management Board Report on the activities of Mabion S.A. for the first half of 2025). It contains detailed financial data, management commentary, and operational updates for a period shorter than a full fiscal year (H1 2025). It meets the criteria for an Interim/Quarterly Report as it provides substantive financial statements and analysis rather than just an announcement. H1 2025
2025-10-08 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.